Conditions we treat
Ketamine for PTSD: What Tampa Patients Should Know
For some adults with post-traumatic stress disorder that has not improved with standard treatments, ketamine therapy may be considered as part of a supervised care plan. Here is what research suggests — and what it cannot promise.
Understanding PTSD and its standard treatments
Post-traumatic stress disorder can follow experiences such as combat, assault, accidents, or other trauma. Symptoms often include intrusive memories, hypervigilance, avoidance, sleep disruption, and a sense of disconnection from other people.
First-line treatments are trauma-focused psychotherapies — such as prolonged exposure, cognitive processing therapy, and EMDR — and certain antidepressant medications. These help many people, but not everyone, and some people continue to have significant symptoms after trying them.
Where ketamine may fit
Early clinical studies, including a randomized controlled trial published in 2014, suggest that IV ketamine may reduce PTSD symptom severity for some patients in the short term. That research is promising but still limited: studies are small, follow-up periods are short, and ketamine is not FDA-approved for PTSD.
Because of that, ketamine therapy for PTSD is considered an off-label option — typically discussed only after standard treatments have been tried without adequate relief, and always as one part of a broader plan that usually includes ongoing psychotherapy.
- Considered off-label, never as a first-line treatment
- Best viewed as a complement to trauma-focused therapy, not a substitute
- Eligibility is determined individually after a full clinical evaluation
What the evidence can and cannot tell us
Honest framing matters here. Current evidence suggests ketamine may offer short-term symptom relief for some people with PTSD. It does not show that ketamine resolves PTSD permanently, and researchers do not yet know how durable benefits are or exactly which patients are most likely to respond.
Any clinic that promises you a specific outcome for PTSD is overstating the science. We will always describe the research to you as it actually stands.
Safety considerations specific to PTSD
Ketamine causes temporary dissociative effects, which some people with trauma histories can find distressing. Our clinical team prepares every patient for what a session may feel like, monitors throughout, and plans aftercare. People with certain conditions — such as uncontrolled blood pressure, active psychosis, or certain substance-use histories — may not be candidates.
If you experience suicidal thoughts, tell us during evaluation so we can plan care appropriately — and if you are in crisis now, call or text 988 or call 911 instead of using this site.
Taking the next step in Tampa
If you live in the Tampa Bay area and standard PTSD treatments have not brought enough relief, a consultation is the right starting point. We will review your history, discuss whether ketamine therapy may be worth considering, and coordinate with your existing therapist or psychiatrist whenever you want us to.
Common questions
No. Ketamine is FDA-approved as an anesthetic; its use for PTSD is off-label. That is a legal and common type of prescribing, but it means the FDA has not evaluated ketamine specifically as a PTSD treatment.
No, and we would not recommend that. Trauma-focused psychotherapy remains the best-supported treatment for PTSD. Ketamine therapy, when considered, works alongside ongoing therapeutic care.
Temporary dissociation and anxiety can occur during sessions. Our team prepares you beforehand, stays with you throughout, and adjusts the plan if a session is difficult. You are never alone in the room.
Candidacy depends on your diagnosis, treatment history, medical conditions, and current medications. The only reliable way to find out is a clinical evaluation — our candidacy page describes the general factors we consider.
Sources & further reading
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder: A Randomized Clinical Trial — JAMA Psychiatry (via PubMed). Accessed 2026-07-23. Feder et al., 2014 — early RCT evidence; short follow-up.
- PTSD: National Center for PTSD — U.S. Department of Veterans Affairs. Accessed 2026-07-23.
- FDA warns patients and health care providers about potential risks associated with compounded ketamine products — U.S. Food and Drug Administration. Accessed 2026-07-23.
Links point to external organizations. Clear Ketamine Therapy does not control their content.
Reviewed by Editorial team (clinical review pending — see LAUNCH_CHECKLIST.md) · Last reviewed 2026-07-23. Medical reviewer: [Medical reviewer to be named before launch]. Educational information only — not medical advice or a substitute for care from your own clinicians.
Keep reading
- Am I a Candidate?Candidacy for ketamine therapy depends on your diagnosis, treatment history, health, and medications. Learn the factors clinicians weigh — and the next step.
- Safety & Side EffectsThe full safety picture: common short-term side effects, who should not receive ketamine, the FDA's compounded-ketamine warning, and our monitoring practices.
- What to ExpectA plain-language walkthrough of the full treatment process at our Tampa clinic — the evaluation, the sessions themselves, and the follow-up — including the parts that vary from person to person.
- Ketamine Therapy TampaPhysician-supervised ketamine therapy for adults in Tampa, Florida — what it is, who it may help, and how to take the first step.
Talk with our clinical team
A consultation is a conversation, not a commitment. Ask questions, share what you are comfortable sharing, and learn whether ketamine therapy may be worth considering for you.
Not for emergencies — call or text 988 or 911 if you are in crisis.